- Home
- DOMO vs AQST Comparison
DOMO vs AQST Comparison
Compare DOMO & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- AQST
- Stock Information
- Founded
- DOMO 2010
- AQST 2004
- Country
- DOMO United States
- AQST United States
- Employees
- DOMO N/A
- AQST N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- DOMO Technology
- AQST Health Care
- Exchange
- DOMO Nasdaq
- AQST Nasdaq
- Market Cap
- DOMO 336.9M
- AQST 285.4M
- IPO Year
- DOMO 2018
- AQST 2018
- Fundamental
- Price
- DOMO $8.16
- AQST $3.01
- Analyst Decision
- DOMO Hold
- AQST Strong Buy
- Analyst Count
- DOMO 6
- AQST 8
- Target Price
- DOMO $10.25
- AQST $10.38
- AVG Volume (30 Days)
- DOMO 352.7K
- AQST 2.0M
- Earning Date
- DOMO 03-06-2025
- AQST 03-05-2025
- Dividend Yield
- DOMO N/A
- AQST N/A
- EPS Growth
- DOMO N/A
- AQST N/A
- EPS
- DOMO N/A
- AQST N/A
- Revenue
- DOMO $318,458,000.00
- AQST $58,900,000.00
- Revenue This Year
- DOMO $0.94
- AQST $18.44
- Revenue Next Year
- DOMO N/A
- AQST N/A
- P/E Ratio
- DOMO N/A
- AQST N/A
- Revenue Growth
- DOMO 0.01
- AQST 22.56
- 52 Week Low
- DOMO $6.11
- AQST $2.24
- 52 Week High
- DOMO $11.87
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- DOMO 46.98
- AQST 43.29
- Support Level
- DOMO $8.25
- AQST $2.95
- Resistance Level
- DOMO $9.25
- AQST $3.21
- Average True Range (ATR)
- DOMO 0.48
- AQST 0.20
- MACD
- DOMO -0.06
- AQST 0.02
- Stochastic Oscillator
- DOMO 3.52
- AQST 18.42
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.